phosphatidylcholines has been researched along with Leishmaniasis, Cutaneous in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbasi, A; Arabsalmani, M; Badiee, A; Chavoshian, O; Jaafari, MR; Khamesipour, A; Saberi, Z | 1 |
| Bosschaerts, T; Fortin, A; Martel, C; Olivier, M; Paquet, M; Shio, MT; Stienstra, S | 1 |
| Bosschaerts, T; Caridha, DP; Fortin, A; Grogl, M; Hickman, MR; Hudson, TH; Leed, S; Ngundam, F; Parriott, S; Sena, J | 1 |
| Carneiro, G; Fernandes, AP; Ferreira, LA; Ferreira, LS; Nunan, EA; Oliveira, MC; Ramaldes, GA; Santos, DC | 1 |
| Huang, Z; Iman, M; Jaafari, MR; Szoka, FC | 1 |
| Alves, IC; Amato, VS; Floeter-Winter, LM; Kono, A; Maldonado, TP; Neto, VA; Rabello, A; Rotondo-Silva, A; Shikanai-Yasuda, MA | 1 |
| Amato Neto, V; Amato, VS; Bacha, HA; Campos, A; Nicodemo, AC; Shikanai-Yasuda, MA; Tuon, FF | 1 |
| Aronson, NE; Davis, C; Fraser, SL; Jackson, JD; Miller, RS; Oster, CN; Wortmann, GW | 1 |
| Barenholz, Y; Frankenburg, S; Glick, D; Klaus, S | 1 |
| Croft, SL; Yardley, V | 1 |
1 trial(s) available for phosphatidylcholines and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B.
Topics: Aged; Amphotericin B; Antiprotozoal Agents; Drug Combinations; Female; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects | 2007 |
9 other study(ies) available for phosphatidylcholines and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
A Phospholipase-A Activity in Soluble
Topics: Adjuvants, Immunologic; Antigens, Protozoan; Drug Compounding; Drug Stability; Enzyme Assays; Humans; Hydrogen-Ion Concentration; Hydrolysis; Leishmania major; Leishmaniasis Vaccines; Leishmaniasis, Cutaneous; Liposomes; Phosphatidylcholines; Phospholipases A; Protozoan Proteins; Sphingomyelins | 2020 |
Drug delivery by tattooing to treat cutaneous leishmaniasis.
Topics: Animals; Cell Line; Female; Leishmania; Leishmaniasis, Cutaneous; Liposomes; Macrophages; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Tattooing | 2014 |
Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Phosphorylcholine | 2014 |
Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Cholesterol; Female; Leishmaniasis, Cutaneous; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Particle Size; Phosphatidylcholines; Skin | 2010 |
Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Cell Culture Techniques; Cell Line; Erythrocytes; Female; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Phosphatidylcholines; Rabbits; Stigmasterol | 2011 |
Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antiprotozoal Agents; Drug Combinations; Humans; Immunocompromised Host; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis.
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Humans; Leishmaniasis, Cutaneous; Male; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.
Topics: Administration, Topical; Amphotericin B; Animals; Antiprotozoal Agents; Cholesterol Esters; Drug Combinations; Ethanol; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred CBA; Micelles; Phosphatidylcholines; Phosphatidylglycerols; Skin Absorption; Solvents; Time Factors; Tissue Distribution | 1998 |
A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cricetinae; Dose-Response Relationship, Drug; Drug Combinations; Female; Leishmania donovani; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Macrophages; Mesocricetus; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Phosphatidylglycerols | 2000 |